DK179086D0 - Angiogen faktor samt dens fremstilling og anvendelse - Google Patents

Angiogen faktor samt dens fremstilling og anvendelse

Info

Publication number
DK179086D0
DK179086D0 DK179086A DK179086A DK179086D0 DK 179086 D0 DK179086 D0 DK 179086D0 DK 179086 A DK179086 A DK 179086A DK 179086 A DK179086 A DK 179086A DK 179086 D0 DK179086 D0 DK 179086D0
Authority
DK
Denmark
Prior art keywords
angiogen
factor
manufacturing
angiogen factor
Prior art date
Application number
DK179086A
Other languages
Danish (da)
English (en)
Other versions
DK179086A (da
Inventor
Nicholas Catsimpoolas
Harry Goldsmith
Original Assignee
Univ Boston
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Boston filed Critical Univ Boston
Publication of DK179086A publication Critical patent/DK179086A/da
Publication of DK179086D0 publication Critical patent/DK179086D0/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Physiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Inorganic Insulating Materials (AREA)
  • Compositions Of Oxide Ceramics (AREA)
  • Peptides Or Proteins (AREA)
DK179086A 1984-08-20 1986-04-18 Angiogen faktor samt dens fremstilling og anvendelse DK179086D0 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US64262484 1984-08-20
US06/642,624 US4699788A (en) 1984-08-20 1984-08-20 Angiogenic factor methods of extraction and method for producing angiogenesis
PCT/US1985/001445 WO1986001111A1 (fr) 1984-08-20 1985-08-01 Facteur d'angiogenese et procede d'obtention d'angiogenese
US8501445 1985-08-01

Publications (2)

Publication Number Publication Date
DK179086A DK179086A (da) 1986-04-18
DK179086D0 true DK179086D0 (da) 1986-04-18

Family

ID=24577348

Family Applications (1)

Application Number Title Priority Date Filing Date
DK179086A DK179086D0 (da) 1984-08-20 1986-04-18 Angiogen faktor samt dens fremstilling og anvendelse

Country Status (12)

Country Link
US (1) US4699788A (fr)
EP (1) EP0191804A1 (fr)
JP (1) JPS62500026A (fr)
KR (1) KR870700359A (fr)
AU (1) AU584914B2 (fr)
BR (1) BR8506887A (fr)
CA (1) CA1261258A (fr)
DK (1) DK179086D0 (fr)
FI (1) FI861654A (fr)
NO (1) NO861553L (fr)
RO (1) RO94021B (fr)
WO (1) WO1986001111A1 (fr)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4897464A (en) * 1985-04-17 1990-01-30 President And Fellows Of Harvard College Purified protein having angiogenic activity and methods of preparation
US4710490A (en) * 1985-10-01 1987-12-01 Angio Medical Corporation Compositions containing ganglioside molecules with enhanced angiogenic activity
US4767746A (en) * 1985-12-04 1988-08-30 Trustees Of Boston University Method for enhancement of healing of epithelial wounds in mammals
US4778787A (en) * 1985-12-20 1988-10-18 Trustees Of Boston University Method for treatment of angina and myocardial infarctions with omental lipids
US4879114A (en) * 1985-12-20 1989-11-07 Angio-Medical Corporation Lipids from omentum and methods for cosmetic use
US4990333A (en) * 1985-12-20 1991-02-05 Angio Medical Corporation Method for healing bone damage
EP0274547A1 (fr) * 1986-12-18 1988-07-20 Trustees Of Boston University Méthode pour augmenter la guérison de blessures épithéliales chez les mammifères
IL84864A0 (en) * 1986-12-31 1988-06-30 Univ Boston Composition for promoting hair growth containing omental lipids and process for promoting hair growth utilizing the same
GB8708009D0 (en) * 1987-04-03 1987-05-07 Clayton Found Res Injectable soft tissue augmentation materials
US4952404A (en) * 1987-06-19 1990-08-28 President And Fellows Of Harvard College Promotion of healing of meniscal tissue
US4952403A (en) * 1987-06-19 1990-08-28 President And Fellows Of Harvard College Implants for the promotion of healing of meniscal tissue
US4853219A (en) * 1987-08-06 1989-08-01 President And Fellows Of Harvard College Antibodies to angiogenin: immunotherapeutic agents
US4940730A (en) * 1987-10-29 1990-07-10 Takeda Chemical Industries, Ltd. Angiogenesis enhancer
US4879312A (en) * 1988-03-07 1989-11-07 Angio Medical Corporation Method for enhancing or provoking angiogenesis using angiogenically active omega-3 polyunsaturated fatty acids
IE891173L (en) * 1988-04-18 1989-10-18 Univ Utrecht Composition for promoting hair growth in androgenetic¹alopecia and method thereof
WO1996001641A1 (fr) * 1994-07-08 1996-01-25 Sulzer Medizinaltechnik Ag Procede de fabrication de materiaux pour greffe
US5733884A (en) * 1995-11-07 1998-03-31 Nestec Ltd. Enteral formulation designed for optimized wound healing
US6321109B2 (en) 1996-02-15 2001-11-20 Biosense, Inc. Catheter based surgery
US6443974B1 (en) 1996-07-28 2002-09-03 Biosense, Inc. Electromagnetic cardiac biostimulation
WO1998005307A1 (fr) * 1996-08-08 1998-02-12 Localmed, Inc. Procede et appareil d'administration transmurale de medicaments
AU7000398A (en) * 1996-11-05 1998-05-29 Localmed, Inc. Method and device for continuous intralumenal delivery of bioactive substances
ES2293473T3 (es) 1998-02-05 2008-03-16 Biosense Webster, Inc. Administracion intracardiaca de farmaco.
US20030113303A1 (en) * 1998-02-05 2003-06-19 Yitzhack Schwartz Homing of embryonic stem cells to a target zone in tissue using active therapeutics or substances
US20030129750A1 (en) * 1998-02-05 2003-07-10 Yitzhack Schwartz Homing of donor cells to a target zone in tissue using active therapeutics or substances
IL139030A0 (en) * 1998-04-17 2001-11-25 Angiogenix Inc Therapeutic angiogenic factors and methods for their use
US6211157B1 (en) 1998-05-01 2001-04-03 Sulzer Biologics, Inc. Protein mixtures to induce therapeutic angiogenesis
US7087577B2 (en) * 1998-10-16 2006-08-08 Zimmer Orthobiologies, Inc. Method of promoting natural bypass
US6992066B2 (en) * 1998-10-16 2006-01-31 Zimmer Orthobiologics, Inc. Povidone-containing carriers for polypeptide growth factors
US7585670B2 (en) 2001-12-07 2009-09-08 Cytori Therapeutics, Inc. Automated methods for isolating and using clinically safe adipose derived regenerative cells
US7595043B2 (en) 2001-12-07 2009-09-29 Cytori Therapeutics, Inc. Method for processing and using adipose-derived stem cells
US7771716B2 (en) 2001-12-07 2010-08-10 Cytori Therapeutics, Inc. Methods of using regenerative cells in the treatment of musculoskeletal disorders
US8105580B2 (en) 2001-12-07 2012-01-31 Cytori Therapeutics, Inc. Methods of using adipose derived stem cells to promote wound healing
JP4653952B2 (ja) 2001-12-07 2011-03-16 サイトリ セラピューティクス インコーポレイテッド 処理済み脂肪吸引細胞で患者を治療するためのシステムと方法
US7514075B2 (en) 2001-12-07 2009-04-07 Cytori Therapeutics, Inc. Systems and methods for separating and concentrating adipose derived stem cells from tissue
US7651684B2 (en) 2001-12-07 2010-01-26 Cytori Therapeutics, Inc. Methods of using adipose tissue-derived cells in augmenting autologous fat transfer
US9597395B2 (en) 2001-12-07 2017-03-21 Cytori Therapeutics, Inc. Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions
US20050095228A1 (en) 2001-12-07 2005-05-05 Fraser John K. Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders
US7232802B2 (en) * 2001-12-21 2007-06-19 Zimmer Orthobiologics, Inc. Compositions and methods for promoting myocardial and peripheral angiogenesis
US7241874B2 (en) * 2002-06-26 2007-07-10 Zimmer Ortho Biologics, Inc. Rapid isolation of osteoinductive protein mixtures from mammalian bone tissue
US7622562B2 (en) 2002-06-26 2009-11-24 Zimmer Orthobiologics, Inc. Rapid isolation of osteoinductive protein mixtures from mammalian bone tissue
WO2009094340A2 (fr) * 2008-01-26 2009-07-30 Surinder Singh Saini Épiploon et son utilisation
WO2010021993A1 (fr) 2008-08-19 2010-02-25 Cytori Therapeutics, Inc. Procédés d'utilisation de cellules issues du tissu adipeux dans le traitement du système lymphatique et d'une maladie maligne
KR101644534B1 (ko) 2009-05-01 2016-08-01 비미니 테크놀로지스 엘엘씨 조직 및 세포 부유화 이식편의 최적화 시스템, 방법 및 조성물
EP2688576A4 (fr) * 2011-03-25 2014-12-03 Cooperlabs Ltd Extraits d'épiploon extraits à la chaleur, compositions, procédés de préparation et leurs utilisations
IL250881A0 (en) 2017-03-01 2017-06-29 Pali Nazir A process of instant creation of artificial bone tissue
IL257853A (en) 2018-03-04 2019-03-31 Pali Nazir Process for building artificial multifunctional injectable filler

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4229532A (en) * 1978-12-29 1980-10-21 Monsanto Company Production of tumor angiogenesis factor by cell culture
US4229531A (en) * 1978-12-29 1980-10-21 Monsanto Company Production of tumor angiogenesis factor by cell culture
US4209587A (en) * 1978-12-29 1980-06-24 Monsanto Company Production of tumor angiogenesis factor by cell culture
US4225670A (en) * 1978-12-29 1980-09-30 Monsanto Company Production of tumor angiogenesis factor by cell culture
US4210718A (en) * 1978-12-29 1980-07-01 Monsanto Company Production of tumor angiogenesis factor by cell culture
US4210719A (en) * 1978-12-29 1980-07-01 Monsanto Company Production of tumor angiogenesis factor by cell culture
US4217412A (en) * 1979-04-25 1980-08-12 President And Fellows Of Harvard College Production of tumor angiogenesis factor by cell culture
US4273871A (en) * 1980-03-03 1981-06-16 Monsanto Company Production of angiogenic factor by cell culture
US4268629A (en) * 1980-03-03 1981-05-19 Monsanto Company Production of angiogenic factor by cell culture
CA1168980A (fr) * 1980-04-17 1984-06-12 Rolf Schafer Compositions cicatrisantes
ZA833446B (en) * 1982-05-28 1984-02-29 Solco Basel Ag Process for the preparation of cell-and tissue-regenerating substances
US4529590A (en) * 1982-12-27 1985-07-16 Leveen Robert F Production of angiogenetic factor

Also Published As

Publication number Publication date
AU584914B2 (en) 1989-06-08
FI861654A0 (fi) 1986-04-18
DK179086A (da) 1986-04-18
CA1261258A (fr) 1989-09-26
KR870700359A (ko) 1987-12-28
US4699788A (en) 1987-10-13
JPS62500026A (ja) 1987-01-08
NO861553L (no) 1986-04-18
AU4638785A (en) 1986-03-07
EP0191804A1 (fr) 1986-08-27
RO94021A (fr) 1988-03-30
WO1986001111A1 (fr) 1986-02-27
BR8506887A (pt) 1986-12-09
FI861654A (fi) 1986-04-18
RO94021B (ro) 1988-03-31

Similar Documents

Publication Publication Date Title
DK179086D0 (da) Angiogen faktor samt dens fremstilling og anvendelse
DK344185A (da) Membraner samt fremstilling deraf
NO162422C (no) Kampolymerer samt fremstilling og anvendelse derav.
NL930085I1 (nl) Benzoylfenylurea
DK570182A (da) Budbringer-rna samt fremstilling og anvendelse deraf
DK433485A (da) Vaeksthormonfrigivende faktor
DK311984A (da) Human tumornecrosisfaktor samt dens anvendelse og fremstilling
KR850010660U (ko) 저장고
DK311884A (da) Calcitoninforbindelse samt fremstilling og anvendelse deraf
IT1184578B (it) Rivestimenti in lega ricca di silicio
DE3261350D1 (en) Aminocyclitols and their production
DK162804C (da) Dinitroanilinpraeparat samt dettes fremstilling
DK488185D0 (da) N6-benzopyrano- og benzothiopyranoadenosiner
NO168812C (no) Haandteringsanordning
ES295807Y (es) Afilalapices
FI840035A0 (fi) Rengoeringsanordning foer flis
KR880700845A (ko) 신규한 부식방지용 안료와 그의 제조방법 및 용도
FR2574373B1 (fr) Conteneur
PT7432U (pt) Paliteiro com auto-elevacao do palito
SE8402359D0 (sv) Tanks
KR850009289U (ko) 뱃 지
BR6400098U (pt) Piteira com filtros
ES281497Y (es) Envase multiple
ES278837Y (es) Envase multiple
SE8404977D0 (sv) Linlas samt anvendning av detsamma

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment